Skip to main content

Ophthalmic Drugs Market Estimates & Strategy Framework To 2020

In December 2017, Spark Therapeutics received Food and Drug Administration (FDA) approval for the first gene therapy drug in the ophthalmic market-Luxturna (voretigene neparvovec-rzyl). The drug is indicated for ophthalmic diseases associated with RPE65 gene mutation, such as retinitis pigmentosa and Leber’s congenital amaurosis.

Download Free PDF Sample  - https://www.radiantinsights.com/research/ophthalmic--drugs-market/request-sample

Increasing number of strategic mergers, acquisitions, and collaborations make the market for ophthalmic drugs a highly competitive space. However, there is ample scope for consolidation. Premium services and high-volume ancillary value-added businesses deliver supplementary benefits to customers and attract investments in the market. The reimbursement policies for ophthalmic treatment form a diversifying factor in the market.

Companies are constantly launching new products to expand their product portfolio and to attain higher share. For instance, in July 2019, Bausch & Lomb Incorporated announced launch of Ocuvite, an eye vitamin supplement to strengthen the macula for the U.S. market.

Due to increasing awareness of ophthalmic disorders and surge in the demand of these products, ophthalmic drug manufacturers are expanding their presence in the emerging economies by supporting various awareness campaigns in different regions. For instance, in 2016, Alcon announced their support to a public awareness program, Think About Your Eyes. The company committed USD 4 million to support this initiative and to promote awareness pertaining to vision care.

Browse Full Report With TOC  - https://www.radiantinsights.com/research/ophthalmic--drugs-market

Further key findings from the study suggest:

• Anti-VEGF agents dominated the drug class segment in 2019 and is anticipated to register the fastest CAGR of 6.7% over the forecast period

• Retinal disorder held the largest market share in 2019 due to rising prevalence of diabetic retinopathy

• In 2019, macular degeneration was the largest retinal disorder segment and diabetic retinopathy was the fastest growing segment

• Eye drops held the leading ophthalmic drugs market share in 2019 and is projected to witness the highest CAGR during the forecast period as it is the most preferred form of drug delivery used for treating ocular diseases such as acute allergies, corneal ulcers, and glaucoma

Comments

Post a Comment

Popular posts from this blog

Barrier Systems Market Share Till, 2020-2027

The global barrier systems market size is expected to reach USD 24.5 billion by 2025, registering a CAGR of 9.8% from 2020 to 2025, according to a new report by Grand View Research, Inc. The growth can be attributed to their increasing use in commercial, residential, and high-end security applications. Moreover, these solutions enable access to vehicles and pedestrians at crossing points to avoid accidents, thereby increasing their adoption. Download free Sample @  https://www.radiantinsights.com/research/barrier-systems-market/request-sample Numerous vendors offer high-security barrier solutions, which are used in vehicle access control systems to protect critical infrastructure and stop projectile impacts. Furthermore, barrier systems include trigger loops and timers to help reduce traffic congestion. The monitoring and access control solutions ensure that property and assets are protected from thieves. Increasing consumer preference for residential safety and security is...
Post a Comment
Read more

What are the key regional markets in the global Instrument Panel industry?

The 'Global and Chinese Instrument Panel Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Instrument Panel industry with a focus on the Chinese market. The report provides key statistics on the market status of the Instrument Panel manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Click For Request Sampe -  https://www.radiantinsights.com/research/global-and-chinese-instrument-panel-industry-2017-market/request-sample Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2012-2017 market shares for each company. Through the statistical analysis, the report depic...
Post a Comment
Read more

Global Real-time Rendering Solutions Market Analysis, Trends and Future Prospects, 2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Real-time Rendering Solutions Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). Download free PDF sample copy @  https://www.radiantinsights.com/research/global-real-time-rendering-solutions-market-research-report-2019-2023/request-sample In this report, the global Real-time Rendering Solutions market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023. The report firstly introduced the Real-time Rendering Solutions basics: definitions, classifications, applicatio...
Post a Comment
Read more